Skip to main content
. 2008 Jan 23;2008(1):CD004024. doi: 10.1002/14651858.CD004024.pub2

Comparison 2. Event‐free survival.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Event‐free Survival ‐ all studies 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
2 Event‐free Survival ‐ different high‐dose settings 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
2.1 High‐dose sequential therapy without induction 2   Hazard Ratio (Fixed, 95% CI) 0.75 [0.51, 1.12]
2.2 Abbreviated standard induction 7   Hazard Ratio (Fixed, 95% CI) 0.97 [0.84, 1.13]
2.3 Full standard induction 3   Hazard Ratio (Fixed, 95% CI) 0.74 [0.50, 1.10]
3 Event‐free Survival ‐ patients' status at randomisation 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
3.1 Patients irrespectively of disease status 10   Hazard Ratio (Fixed, 95% CI) 0.91 [0.79, 1.04]
3.2 Patients in PR 2   Hazard Ratio (Fixed, 95% CI) 1.08 [0.67, 1.73]
4 Event‐free Survival ‐ methodological quality 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
4.1 Sufficient method 11   Hazard Ratio (Fixed, 95% CI) 0.95 [0.83, 1.08]
4.2 Insufficient or unknown method 1   Hazard Ratio (Fixed, 95% CI) 0.36 [0.18, 0.72]
5 Event‐free Survival ‐ study size 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
5.1 > 100 patients 7   Hazard Ratio (Fixed, 95% CI) 0.96 [0.83, 1.11]
5.2 < 100 patients 5   Hazard Ratio (Fixed, 95% CI) 0.74 [0.55, 1.01]
6 Event‐free Survival ‐ protocol adherence to HDT 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
6.1 > 70% 7   Hazard Ratio (Fixed, 95% CI) 1.03 [0.86, 1.22]
6.2 < 70% 5   Hazard Ratio (Fixed, 95% CI) 0.79 [0.65, 0.97]
7 Event‐free Survival ‐ bone marrow involvement 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
7.1 >20% 5   Hazard Ratio (Fixed, 95% CI) 0.98 [0.82, 1.18]
7.2 <20% 7   Hazard Ratio (Fixed, 95% CI) 0.85 [0.70, 1.03]
8 Event‐free Survival ‐ % of patients with DLCL (wide def.) 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
8.1 > 80% 7   Hazard Ratio (Fixed, 95% CI) 0.80 [0.65, 0.97]
8.2 < 80% 5   Hazard Ratio (Fixed, 95% CI) 1.02 [0.86, 1.21]
9 Event‐free Survival ‐ % of patients with DLCL (narrow def.) 12   Hazard Ratio (Fixed, 95% CI) 0.92 [0.80, 1.05]
9.1 > 70% 6   Hazard Ratio (Fixed, 95% CI) 0.72 [0.58, 0.89]
9.2 < 70% 6   Hazard Ratio (Fixed, 95% CI) 1.06 [0.90, 1.26]
10 Event‐free Survival ‐ IPI groups 11   Hazard Ratio (Fixed, 95% CI) 0.96 [0.84, 1.10]
10.1 IPI ‐ low and low‐intermediate risk 6   Hazard Ratio (Fixed, 95% CI) 1.02 [0.75, 1.37]
10.2 IPI ‐ high‐intermediate and high risk 11   Hazard Ratio (Fixed, 95% CI) 0.95 [0.81, 1.11]